P

Inventor

ADAMS SHARLENE

US13 patents
⚠️ This page may combine multiple inventors who share the name “ADAMS SHARLENE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

POINT THERAPEUTICS INC

3 patents
US6300314B1Oct 9, 2001

Hematopoietic stimulation

POINT THERAPEUTICS INC106 citations97
US7067489B2Jun 27, 2006

Hematopoietic stimulation

POINT THERAPEUTICS INC14 citations91
US6770628B2Aug 3, 2004

Hematopoietic stimulation

POINT THERAPEUTICS INC34 citations91

ANTIGEN EXPRESS INC

3 patents
US6432409B1Aug 13, 2002

Hybrid peptides modulate the immune response

ANTIGEN EXPRESS INC24 citations91
US7205274B2Apr 17, 2007

Hybrid peptides modulate the immune response

ANTIGEN EXPRESS INC6 citations72
US7541334B2Jun 2, 2009

Hybrid peptides modulate the immune response

ANTIGEN EXPRESS INC3 citations61

MERRIMACK PHARMACEUTICALS INC

3 patents
US9556274B2Jan 31, 2017

Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodies

MERRIMACK PHARMACEUTICALS INC2 citations71
US9527914B2Dec 27, 2016

Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies

MERRIMACK PHARMACEUTICALS INC1 citations61
US9938346B2Apr 10, 2018

Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies

MERRIMACK PHARMACEUTICALS INC0 citations50

UNIV MASSACHUSETTS

2 patents
US5919639AJul 6, 1999

Ii peptide therapeutics to enhance antigen presentation

UNIV MASSACHUSETTS40 citations92
US6835382B2Dec 28, 2004

Ii peptide therapeutics to enhance antigen presentation

UNIV MASSACHUSETTS0 citations51

BAUM JASON

1 patent
US8476409B2Jul 2, 2013

Bispecific anti-IGF-1R and anti-ErbB3 antibodies

BAUM JASON22 citations88

IMMUNOGEN INC

1 patent
US11701428B2Jul 18, 2023

Therapeutic combinations comprising anti-CD123 immunoconjugates

IMMUNOGEN INC1 citations50